Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib) Meeting Abstract


Authors: Hong, D. S.; Bang, Y. J.; Barlesi, F.; Durm, G. A.; Falchook, G. S.; Govindan, R.; Dy, G. K.; Park, K.; Strickler, J. H.; Burns, T. F.; Kim, J.; Ang, A.; Lipford, J. R.; Ngarmchamnanrith, G.; Anderson, A.; Li, B. T.
Abstract Title: Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib)
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S812
Language: English
ACCESSION: WOS:000573469101543
DOI: 10.1016/j.annonc.2020.08.1571
PROVIDER: wos
Notes: Meeting Abstract: 1257O -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bob Tingkan Li
    278 Li